UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?

European heart journal, 2005-11, Vol.26 (21), p.2269-2276

2005

Volltextzugriff (PDF)

What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?

European heart journal, 2006-01, Vol.27 (2), p.193-200

2006

Volltextzugriff (PDF)

20 A comparison of two iFR methods to predict FFR (fractional flow reserve) - the blackpool coronary iFR study (BCIS)

Heart (British Cardiac Society), 2016-05, Vol.102 (Suppl 4), p.A10-A10

Galasko, Gavin

2016

Volltextzugriff (PDF)

120The Instantaneous Wave-Free Ratio (IFR) Is An Accurate Predictor of Fractional Flow Reserve (FFR) In Adult Coronary Arteries so Long As a Grey Zone or Hybrid-Approach is used and not Individual Cut-Offs: The Blackpool Coronary IFR (Bcis) Study

Heart (British Cardiac Society), 2015-06, Vol.101 (Suppl 4), p.A68-A69

Galasko, Gavin

2015

Volltextzugriff (PDF)

120 The Instantaneous Wave-Free Ratio (IFR) Is An Accurate Predictor of Fractional Flow Reserve (FFR) In Adult Coronary Arteries so Long As a Grey Zone or Hybrid-Approach is used and not Individual Cut-Offs: The Blackpool Coronary IFR (Bcis) Study

Heart (British Cardiac Society), 2015-06, Vol.101 (Suppl 4), p.A68-A69

Galasko, Gavin

2015

Volltextzugriff (PDF)

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction

The New England journal of medicine, 2022-10, Vol.387 (15), p.1351-1360

2022

Volltextzugriff (PDF)

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

The Lancet (British edition), 2018-09, Vol.392 (10151), p.940-949

2018

Volltextzugriff (PDF)

Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership

Heart (British Cardiac Society), 2023-01, Vol.109 (2), p.88

2023

Volltextzugriff (PDF)

Acute cardiovascular medicine

Clinical medicine (London, England), 2007-06, Vol.7 (3), p.257-261

2007

Volltextzugriff (PDF)

Direct access echocardiography

The International Journal of Cardiovascular Imaging, 2006-02, Vol.22 (1), p.29-31

2006

Volltextzugriff (PDF)

Iatrogenic Aortocoronary Dissection Successfully Treated by Coronary Intervention

Heart international, 2011-01, Vol.6 (2), p.hi.2011.e15-e15

2011

Volltextzugriff (PDF)

Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial

Circulation (New York, N.Y.), 2023-09, Vol.148 (11), p.862

2023

Volltextzugriff (PDF)

The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy-a myriad of techniques

European journal of heart failure, 2003-06, Vol.5 (3), p.217-227

2003

Volltextzugriff (PDF)

Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy

Journal of the American College of Cardiology, 2024-07, Vol.84 (4), p.340-350

2024

Volltextzugriff (PDF)

Wasp sting induced STEMI with complete coronary artery occlusion: a case of Kounis syndrome

BMJ case reports, 2017-09, Vol.2017, p.bcr-2017-221256

2017

Volltextzugriff (PDF)

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial

Circulation Cardiovascular quality and outcomes, 2024-01, Vol.17 (1), p.e010533

2024

Volltextzugriff (PDF)

Impact of established cardiovascular disease on outcomes in the randomized global leaders trial

Catheterization and cardiovascular interventions, 2020-12, Vol.96 (7), p.1369-1378

2020

Volltextzugriff (PDF)

PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY

Journal of the American College of Cardiology, 2019-03, Vol.73 (9), p.245-245

2019

Volltextzugriff (PDF)

Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2

JACC. Heart failure, 2024-04

2024

Volltextzugriff (PDF)

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial

Journal of the American Heart Association, 2022-05, Vol.11 (10), p.e024291-e024291

2022

Volltextzugriff (PDF)

Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction

JACC. Heart failure, 2024-04

2024

Volltextzugriff (PDF)

Energy drinks give you wings but also an abnormal exercise test

BMJ case reports, 2017-07, Vol.2017, p.bcr-2017-220017

2017

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(37)
Dissertationen
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease?

What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?

20 A comparison of two iFR methods to predict FFR (fractional flow reserve) - the blackpool coronary iFR study (BCIS)

120The Instantaneous Wave-Free Ratio (IFR) Is An Accurate Predictor of Fractional Flow Reserve (FFR) In Adult Coronary Arteries so Long As a Grey Zone or Hybrid-Approach is used and not Individual Cut-Offs: The Blackpool Coronary IFR (Bcis) Study

120 The Instantaneous Wave-Free Ratio (IFR) Is An Accurate Predictor of Fractional Flow Reserve (FFR) In Adult Coronary Arteries so Long As a Grey Zone or Hybrid-Approach is used and not Individual Cut-Offs: The Blackpool Coronary IFR (Bcis) Study

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership

Acute cardiovascular medicine

Rationale and design of the Medical Research Council's Precision Medicine with Zibotentan in Microvascular Angina (PRIZE) trial

Direct access echocardiography

Iatrogenic Aortocoronary Dissection Successfully Treated by Coronary Intervention

Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial

The non-invasive assessment of hibernating myocardium in ischaemic cardiomyopathy-a myriad of techniques

Impact of Anatomical and Viability-Guided Completeness of Revascularization on Clinical Outcomes in Ischemic Cardiomyopathy

Wasp sting induced STEMI with complete coronary artery occlusion: a case of Kounis syndrome

Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analysis of the REVIVED-BCIS2 Trial

Impact of established cardiovascular disease on outcomes in the randomized global leaders trial

PREDICTIVE ABILITY OF THE PARIS RISK SCORE IN ALL-COMERS PATIENTS UNDERGOING PCI WITH DRUG ELUTING STENTS: EXTERNAL VALIDATION IN THE GLOBAL LEADERS STUDY

Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial

Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction

Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial

Energy drinks give you wings but also an abnormal exercise test

Conservative versus Invasive Strategy in Elderly Patients with Non-ST-Elevation Myocardial Infarction: Insights from the International POPular Age Registry

Suchergebnisse filtern